These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21528623)

  • 41. Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.
    Delmée M; Vandercam B; Avesani V; Michaux JL
    Eur J Clin Microbiol; 1987 Dec; 6(6):623-7. PubMed ID: 3440454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden.
    Torell E; Cars O; Olsson-Liljequist B; Hoffman BM; Lindbäck J; Burman LG
    J Clin Microbiol; 1999 Nov; 37(11):3509-13. PubMed ID: 10523543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.
    Koh TH; Tan AL; Tan ML; Wang G; Song KP
    Pathology; 2007 Aug; 39(4):438-42. PubMed ID: 17676487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the treatment of vancomycin-resistant enterococcal urinary tract infections in a large academic medical center.
    Heintz BH; Cho S; Fujioka A; Li J; Halilovic J
    Ann Pharmacother; 2013 Feb; 47(2):159-69. PubMed ID: 23341161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
    Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
    Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
    Shin JW; Yong D; Kim MS; Chang KH; Lee K; Kim JM; Chong Y
    J Infect Chemother; 2003 Mar; 9(1):62-7; discussion 104-5. PubMed ID: 12673410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections.
    Mendez MN; Gibbs L; Jacobs RA; McCulloch CE; Winston L; Guglielmo BJ
    Pharmacotherapy; 2006 Jan; 26(1):61-7. PubMed ID: 16509027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.
    Villano SA; Seiberling M; Tatarowicz W; Monnot-Chase E; Gerding DN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5224-9. PubMed ID: 22850511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.
    Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ
    J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy.
    Ray AJ; Hoyen CK; Das SM; Eckstein EC; Donskey CJ
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):474-7. PubMed ID: 12186217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients.
    Wells CL; Juni BA; Cameron SB; Mason KR; Dunn DL; Ferrieri P; Rhame FS
    Clin Infect Dis; 1995 Jul; 21(1):45-50. PubMed ID: 7578758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors.
    Ziakas PD; Zacharioudakis IM; Zervou FN; Grigoras C; Pliakos EE; Mylonakis E
    PLoS One; 2015; 10(2):e0117195. PubMed ID: 25707002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey.
    Mainardi JL; Lacassin F; Guilloy Y; Goldstein FW; Leport C; Acar JF; Vildé JL
    J Infect; 1998 Sep; 37(2):108-11. PubMed ID: 9821082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
    Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
    Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.
    Gambarotto K; Ploy MC; Turlure P; Grélaud C; Martin C; Bordessoule D; Denis F
    J Clin Microbiol; 2000 Feb; 38(2):620-4. PubMed ID: 10655356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
    Song JY; Cheong HJ; Jo YM; Choi WS; Noh JY; Heo JY; Kim WJ
    Am J Infect Control; 2009 Nov; 37(9):734-40. PubMed ID: 19188004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
    Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):709-15. PubMed ID: 18631116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay.
    Rafferty ME; McCormick MI; Bopp LH; Baltch AL; George M; Smith RP; Rheal C; Ritz W; Schoonmaker D
    Infect Control Hosp Epidemiol; 1997 May; 18(5):342-4. PubMed ID: 9154478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.